Maximizing Yield And Purity With Praesto™ CH1 Resin
Antibody purification continues to evolve with the introduction of Praesto® CH1 resin, a breakthrough solution developed through Ecolab’s collaboration with Repligen. Engineered to bind with high affinity to the CH1 domain of human IgG molecules, this resin is optimized for complex antibody-based therapeutics. It offers high productivity, robust pressure-flow performance, and strong resistance to sodium hydroxide—making it ideal for GMP manufacturing environments. By simplifying the capture step and enhancing contaminant removal, Praesto CH1 helps streamline workflows and improve yield.
Whether you're scaling up or refining your purification strategy, this innovation supports consistent, high-quality results. Learn how it can elevate your process and keep you at the forefront of therapeutic development.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.